Results of a phase 1 study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children and young adults with brain cancer

Neuro-Oncology

Volumn 6, Issue 3, 2004, Pages 236-246

  Caruso, Denise A ^a,c,d   Orme, Lisa M ^a   Neale, Alana M ^a,d   Radcliff, Fiona J ^a   Armor, Gerlinda M ^a,d   Maixner, Wirginia ^a   Downie, Peter ^a   Hassall, Timothy E ^b,d   Tang, Mimi L K ^a,d   Ashley, David M ^a,c,d  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; RNA;

ADOLESCENT; ADOPTIVE IMMUNOTHERAPY; ADULT; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; BRAIN CANCER; CANCER IMMUNOTHERAPY; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENDRITIC CELL; DOSE RESPONSE; DRUG SAFETY; FEMALE; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNE RESPONSE; LEUKAPHERESIS; MALE; MONOCYTE; PHASE 1 CLINICAL TRIAL; RECURRENT CANCER; SCHOOL CHILD;

ADOLESCENT; ADULT; ANTIBODIES, NEOPLASM; BRAIN NEOPLASMS; CANCER VACCINES; CHILD; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-10; LYMPHOCYTE COUNT; MALE; MONOCYTES; RNA, NEOPLASM; STATISTICS, NONPARAMETRIC;

EID: 4344560470     PISSN: 15228517     EISSN: None     Source Type: Journal    
DOI: 10.1215/S1152851703000668     Document Type: Article

References (23)

1. Ashley, D.M., and Bigner, D.D. (1997). Recent advances in the biology of central nervous system tumors. Curr. Opin. Neurol. 10, 445-451.
2. Ashley, D.M., Faiola, B., Nair, S., Hale, L.P., Bigner, D.D., and Gilboa, E. (1997) Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors. J. Exp. Med. 186, 1177-1182.
3. Bergsagel, D.E. (1971) An assessment of massive-dose chemotherapy of malignant disease. Can. Med. Assoc J. 104, 31-36.
4. Bullard, D.E., Thomas, D.G., Darling, J.L., Wikstrand, C.J., Diengdoh, J.V, Barnard, R.O., Bodmer, J.G., and Bigner, D.D. (1985) A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas. Br. J. Cancer 51, 283-289.
5. Cinque, S., Willems, J., Depraetere, S., Vermeire, L., and Joniau, M. (1992) "In vitro" effect of interleukin-1 beta on human glioma cell lines: Regulation of cell proliferation and IL-6 production. Immunol. Lett. 34, 267-271.
6. De Vries, I.J., Krooshoop, D.J., Scharenborg, N.M., Lesterhuis, W.J., Diepstra, J.H., Van Muijen, G.N., Strijk, S.P., Ruers, TJ., Boerman, O.C., Oyen, W.J., Adema, G.J., Punt, C.J. and Figdor, C.G. (2003) Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res. 63, 12-17.
7. Dhodapkar, M.V., Krasovsky, J., Steinman, R.M., and Bhardwaj, N. (2000) Mature dendritic cells boost functionally superior CD8(+) T-cell in humans without foreign helper epitopes. J. Clin. Invest. 105, R9-R14.
8. Geiger, J.D., Hutchinson, R.J., Hohenkirk, L.F., McKenna, E.A., Yanik, G.A., Levine, J.E., Chang, A.E., Braun, T.M., and Mule, J.J. (2001) Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression. Cancer Res., 8513-8519.
9. Heiser, A., Dahm, P, Yancey, D.R., Maurice, M.A., Boczkowski, D., Nair, S.K., Gilboa, E., and Vieweg, J. (2000) Human dendritic cells transfected with RNA encoding prostate-specific antigen stimulate prostate-specific CTL responses in vitro. J. Immunol. 164, 5508-5514.
10. Hosking, C.S., and Balloch, A. (1983) A formula to assess lymphocyte responsiveness in vitro. Birth Defects Orig. Article Ser. 19, 21-23.
11. Huettner, C., Paulus, W., and Roggendorf, W. (1995) Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas. Am. J. Pathol. 146, 317-322.
12. Mitchell, A.E., Elder, J.E., Mackey, D.A., Waters, K.D., and Ashley, D.M. (2001) Visual improvement despite radiologically stable disease after treatment with carboplatin in children with progressive low-grade optic/thalamic gliomas. J. Pediatr. Hematol. Oncol. 23, 572-577.
13. Murphy, J.B., and Sturm, E. (1923) Conditions determining the transplantability of tissues in the brain. J. Exp. Med. 38, 183-197.
14. NCI. National Cancer Institute, Cancer Therapy Evaluation Program (1999) Common Toxicity Criteria-Version 2.0. Rockville, Md.: NCI Division of Cancer Treatment and Diagnosis (available at http://ctep.cancer.gov/reporting/ctc.html).
15. Porgador, A., and Gilboa, E. (1995) Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J. Exp. Med. 182, 255-260.
16. Romani, N., Reider, D., Heuer, M., Ebner, S., Kampgen, E., Eibl, B., Niederwieser, D., and Schuler, G. (1996) Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J. Immunol. Methods 196, 137-151.
17. Sampson, J.H., Crotty, L.E., Lee, S., Archer, G.E., Ashley, D.M., Wikstrand, C.J., Hale, L.P., Small, C., Dranoff, G., Friedman, A.H., Friedman, H.S., and Bigner, D.D. (2000) Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors. Proc. Natl. Acad. Sci. USA 97, 7503-7508.
18. Shelton, M.S., Meek, F., and Hoskings, C.S. (1974) Serum immunoglobulin levels in children. Aust J. Med. Technol. 5, 113.
19. Shirai, Y. (1923) Transplantations of rat sarcomas in adult heterogeneous animals. Jpn. Med. World 1, 14-15.
20. Simonsen, O., Bentzon, M.W., and Heron, I. (1986) ELISA for the routine determination of antitoxic immunity to tetanus. J. Biol. Stand. 14, 231-239.
21. Stockwin, L.H., McGonagle, D., Martin, I.G., and Blair, G.E. (2000) Dendritic cells: Immunological sentinels with a central role in health and disease. Immunol. Cell Biol. 78, 91-102.
22. Tada, M., and de Tribolet, N. (1993) Recent advances in immunobiology of brain tumors. J. Neurooncol. 17, 261-271.
23. Yu, J.S., Wheeler, C.J., Zeltzer, P.M., Ying, H., Finger, D.N., Lee, P.K., Yong, W.H., Incardona, F., Thompson, R.C., Riedinger, M.S., Zhang, W., Prins, R.M., and Black, K.L. (2001) Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration. Cancer Res. 61, 842-847.